After rejecting approval twice, FDA has approved Furoscix (ScPharmaceuticals).

Lauren Howell, PharmD

Once the COVID-19 public health emergency (PHE) is lifted, COVID-19 tests, treatments, and vaccines will no longer be “free” for all.

Clarissa Chan, PharmD

Insulin rationing is common among adults with type 1 or type 2 diabetes.

Sonya Collins

Pharmacy Today proudly presents APhA’s Self-Care Product Survey.

A Connecticut court recently issued a ruling that places an otherwise “ordinary” pharmacist duty to warn case into the category of “interesting.”

David B. Brushwood, BSPharm, JD

Extended rivaroxaban treatment could reduce risk of recurrent venous thromboembolism.

In an effort to better understand and diagnose long COVID, researchers of a new study published October 10, 2022, in JAMA looked at the proportion of individuals who experienced common self-reported long COVID symptom clusters 3 months after initial symptomatic SARSCoV-2 infection in 2020 and 2021.

Mariecus CM Jarvis-Mays, PharmD, MEd

The ever-rising complexity of patient health has prompted the Society for Perioperative Assessment and Quality Improvement (SPAQI) to address the lack of resources for perioperative medication management through publication of their own guidance.

Olivia C. Welter, PharmD

Influenza hospitalizes as many as 45,000 children per year. The virus causes up to 600 annual deaths in the pediatric population.

Sonya Collins

Over the past decade, reported morbidity and mortality rates from community acquired pneumonia (CAP) have stagnated.

Corey Diamond, PharmD